Does Aridis Pharmaceuticals Inc. (NASDAQ:ARDS) have deteriorating prospects?

Aridis Pharmaceuticals Inc. (NASDAQ:ARDS) shares traded 4.15% higher at $0.35 on Wall Street last session. In accordance with the data, 1 analysts cover Aridis Pharmaceuticals Inc. (NASDAQ:ARDS). The consensus rating among analysts is ‘Buy’. As we calculate the median target price by taking the range between a high of $2.00 and a low of $2.00, […]